177 related articles for article (PubMed ID: 36614872)
1. Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis.
Marín-Rosales M; Palafox-Sánchez CA; Franco-Topete RA; Carrillo-Ballesteros FJ; Cruz A; Salazar-Camarena DC; Muñoz-Valle JF; Ramos-Solano F
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614872
[TBL] [Abstract][Full Text] [Related]
2. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
[TBL] [Abstract][Full Text] [Related]
3. Profile of BAFF and its receptors' expression in lupus nephritis is associated with pathological classes.
Suso JP; Posso-Osorio I; Jiménez CA; Naranjo-Escobar J; Ospina FE; Sánchez A; Cañas CA; Tobón GJ
Lupus; 2018 Apr; 27(5):708-715. PubMed ID: 29087261
[TBL] [Abstract][Full Text] [Related]
4. Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers.
Aguirre-Valencia D; Ríos-Serna LJ; Posso-Osorio I; Naranjo-Escobar J; López D; Bedoya-Joaqui V; Nieto-Aristizábal I; Castro AM; Díaz-Ordoñez L; Navarro EP; Barrera MC; Echeverri A; Cañas CA; Tobón GJ
J Transl Autoimmun; 2020; 3():100027. PubMed ID: 32743512
[TBL] [Abstract][Full Text] [Related]
5. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
[TBL] [Abstract][Full Text] [Related]
6. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
8. BAFF system expression in double negative 2, activated naïve and activated memory B cells in systemic lupus erythematosus.
Álvarez Gómez JA; Salazar-Camarena DC; Román-Fernández IV; Ortiz-Lazareno PC; Cruz A; Muñoz-Valle JF; Marín-Rosales M; Espinoza-García N; Sagrero-Fabela N; Palafox-Sánchez CA
Front Immunol; 2023; 14():1235937. PubMed ID: 37675114
[TBL] [Abstract][Full Text] [Related]
9. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
[TBL] [Abstract][Full Text] [Related]
10. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.
Jacob CO; Yu N; Sindhava V; Cancro MP; Pawar RD; Putterman C; Stohl W
Arthritis Rheumatol; 2015 Sep; 67(9):2523-35. PubMed ID: 25989238
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of IFN-α, IL-12 and BAFF on renal immune cells and its relevance to disease activity and treatment responsiveness in patients with proliferative lupus nephritis.
Nawata A; Nakayamada S; Hisano S; Miyazaki Y; Miyamoto T; Shiba E; Hisaoka M; Tanaka Y
Lupus Sci Med; 2023 Jul; 10(2):. PubMed ID: 37460249
[TBL] [Abstract][Full Text] [Related]
12. The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus.
Sari S; Cinar S; Yalcinkaya Y; Artim-Esen B; Ozluk Y; Gul A; Ocal L; Deniz G; Inanc M
Lupus; 2022 Apr; 31(5):555-564. PubMed ID: 35249405
[TBL] [Abstract][Full Text] [Related]
13. Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.
Ortiz-Aljaro P; Montes-Cano MA; García-Lozano JR; Aquino V; Carmona R; Perez-Florido J; García-Hernández FJ; Dopazo J; González-Escribano MF
Sci Rep; 2022 Jul; 12(1):11219. PubMed ID: 35780200
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
15. Association between early immunophenotypic changes and therapeutic response of belimumab in patients with systemic lupus erythematosus.
Hirano A; Fujioka K; Kida T; Omura S; Sofue H; Sakashita A; Sagawa T; Isoda Y; Kasahara A; Sagawa R; Fujii W; Seno T; Wada M; Kohno M; Kawahito Y
Lupus; 2023 Jan; 32(1):63-73. PubMed ID: 36317306
[TBL] [Abstract][Full Text] [Related]
16. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
[TBL] [Abstract][Full Text] [Related]
18. Intrarenal production of B-cell survival factors in human lupus nephritis.
Neusser MA; Lindenmeyer MT; Edenhofer I; Gaiser S; Kretzler M; Regele H; Segerer S; Cohen CD
Mod Pathol; 2011 Jan; 24(1):98-107. PubMed ID: 20890272
[TBL] [Abstract][Full Text] [Related]
19. Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma.
Birnbaum T; Langer S; Roeber S; von Baumgarten L; Straube A
Neurol Int; 2013 Feb; 5(1):e4. PubMed ID: 23717783
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
